E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −10,177−100.0% | Sold out | Holders |
| Q2 2024 | 10,177 | $41.6K | <0.1% | −3,906−27.7% | Reduced | Holders |
| Q1 2024 | 14,083 | $221.9K | <0.1% | −5,257−27.2% | Reduced | Holders |
| Q4 2023 | 19,340 | $293.0K | <0.1% | +9,033+87.6% | Added | Holders |
| Q3 2023 | 10,307 | $207.0K | <0.1% | −3,185−23.6% | Reduced | Holders |
| Q2 2023 | 13,492 | $381.0K | <0.1% | +1,671+14.1% | Added | Holders |
| Q1 2023 | 11,821 | $203.0K | <0.1% | −195−1.6% | Reduced | Holders |
| Q4 2022 | 12,016 | $242.0K | <0.1% | −612−4.8% | Reduced | Holders |
| Q3 2022 | 12,628 | $274.0K | <0.1% | −1,728−12.0% | Reduced | Holders |
| Q2 2022 | 14,356 | $403.0K | <0.1% | +8,277+136.2% | Added | Holders |
| Q1 2022 | 6,079 | $280.0K | <0.1% | +6,079 | New | Holders |